Annual Report 2020

Bayer Delivers Robust Performance despite Pandemic – Foundation Laid for Future Growth

Explore Your Topic

Bayer to Manufacture mRNA Vaccine in Germany

Inclusion & Diversity

Bayer Strives for Gender Parity in All Management Levels by 2030

Bayer Accelerates Crop Science Division Transformation

Our Products

Can We Live Better?

Can 10 billion of us live better?

Board of Management of Bayer AG

Sarena Lin – New Chief Transformation and Talent Officer

Sustainability Report 2020

Bayer’s Entrepreneurial and Social Responsibility Go Hand in Hand

Uses and Safety Record

Let’s Talk About Glyphosate

Links

Information for Patients

Modern Slavery Act Statement.pdf (PDF 2.05 MB)

Latest News

Share Price / Index

March 4, 2021 12:59 CEST

March 4, 2021 13:00 CEST

February 25, 2021

Fiscal 2020:

Bayer delivers robust performance despite pandemic – foundation laid for future growth

February 24, 2021

Bayer to Divest Environmental Science Professional Business and Further Strengthen Leadership Team of Crop Science Division

February 09, 2021

Not intended for U.S. and UK Media

Bayer submits finerenone for marketing authorization in China for the treatment of chronic kidney disease in type 2 diabetes

Advance Your Career

Why Bayer

Working at Bayer

Meet Our Employees

Open Jobs

Senior Clinical Pharmacology Lead Oncology (m/f/d)

Data Scientist (m/f/d)

Biologielaborant Qualitätskontrolle Biologika Schwerpunkt Zellbiologie (m/w/d)

Germany Wuppertal-Elberfeld

Explore Our Businesses

We address some of the world's most pressing global challenges and continue to develop new solutions. The population is constantly growing and its age is increasing. That is why it needs better medicines and high-quality food in sufficient quantities. Learn more about it here.

Pharmaceuticals

Consumer Health